HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

PD-L1 status and Immune checkpoint inhibitors in kidney cancer: ignorance, lack of knowledge or both.

AuthorsHossein Tezval, Jan Hinrich Braesen, Markus A Kuczyk
JournalWorld journal of urology (World J Urol) Vol. 40 Issue 3 Pg. 887-888 (03 2022) ISSN: 1433-8726 [Electronic] Germany
PMID33582832 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • B7-H1 Antigen
  • Biomarkers, Tumor
  • Immune Checkpoint Inhibitors
Topics
  • B7-H1 Antigen
  • Biomarkers, Tumor
  • Humans
  • Immune Checkpoint Inhibitors (therapeutic use)
  • Kidney Neoplasms (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: